Key facts
- This page summarizes Richard K. Templeton's Form 4 filing for TEXAS INSTRUMENTS INC (TXN).
- 15 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2025, 16:28.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Options Exercise
Sale
Sale
Sale
Sale
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $191.25 to $192.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F2
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $192.25 to $192.975. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F3
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $193.405 to $194.39. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F4
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $194.41 to $195.4. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F5
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $195.415 to $196.41. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F6
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $196.42 to $197.38. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F7
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $197.42 to $197.945. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F8
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $191.62 to $192.595. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F9
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $192.805 to $193.62. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F10
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $194.215 to $195.105. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F11
The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $195.275 to $196.04. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
Footnote F12
Estimated shares attributable to TI 401(k) Account as of 12/31/2024. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in this account occurring after 12/31/2024 that are eligible for deferred reporting on Form 5.
Footnote F13
Estimated shares attributable to TI Universal Profit Sharing Account as of 12/31/2024. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in such account occurring after 12/31/2024 that are eligible for deferred reporting on Form 5.
Footnote F14
Shares held in trusts for benefit of children; beneficial ownership by reporting person disclaimed.
Footnote F15
The option became exercisable in four equal annual installments beginning on January 29, 2017.